BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27877199)

  • 1. Revision of the dosimetric parameters of the CSM11 LDR Cs-137 source.
    Otal A; Martínez-Fernández JM; Granero D
    J Contemp Brachytherapy; 2011 Mar; 3(1):36-39. PubMed ID: 27877199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BEBIG
    Joya M; Nedaie HA; Geraily G; Ghorbani M; Sheikhzadeh P; Arani MN
    Heliyon; 2022 Mar; 8(3):e09168. PubMed ID: 35368537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
    Casado FJ; García-Pareja S; Cenizo E; Mateo B; Bodineau C; Galán P
    Phys Med; 2010; 26(3):132-9. PubMed ID: 20034828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TG-43 U1 based dosimetric characterization of model 67-6520 Cs-137 brachytherapy source.
    Meigooni AS; Wright C; Koona RA; Awan SB; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Oct; 36(10):4711-9. PubMed ID: 19928102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SU-E-T-467: Monte Carlo Dosimetric Study of the New Flexisource Co-60 High Dose Rate Source.
    Vijande J; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2012 Jun; 39(6Part17):3812. PubMed ID: 28517443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric study of GZP6
    Lei Q; Xu A; Gou C; Wen Y; He D; Wu J; Hou Q; Wu Z
    J Appl Clin Med Phys; 2018 Jul; 19(4):313-318. PubMed ID: 29808551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric comparison between microSelectron iridium-192 and flexi cobalt-60 sources in high-dose-rate brachytherapy using Geant4 Monte Carlo code.
    Gebremariam TY; Geraily G; Jassim HH; Gholami S
    J Contemp Brachytherapy; 2023 Apr; 15(2):141-147. PubMed ID: 37215615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo Study on Dose Distributions Around
    Mishra S; Mishra B; Selvam TP; Deshpande S; Pathan MS; Kumar R
    J Med Phys; 2022; 47(3):270-278. PubMed ID: 36684701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
    Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
    Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte Carlo dosimetric study of the medium dose rate CSM40 source.
    Vijande J; Granero D; Perez-Calatayud J; Ballester F
    Appl Radiat Isot; 2013 Dec; 82():283-8. PubMed ID: 24121444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of task group 43 dosimetric parameters for CSM40
    Firoozabadi MM; Jimabadi E; Ghorbani M; Behmadi M
    Radiol Phys Technol; 2018 Mar; 11(1):82-90. PubMed ID: 29299819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo dosimetry of a new (90)Y brachytherapy source.
    Junxiang W; Shihu Y; Jing H; Fengxiang L; Chengkai W; Zhangwen W; Qing H; Chengjun G
    J Contemp Brachytherapy; 2015 Oct; 7(5):397-406. PubMed ID: 26622247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of TG-43 Dosimetric Parameters for
    Joya M; Nedaie HA; Geraily G; Rezaei H; Bromand A; Ghorbani M; Sheikhzadeh P
    J Med Phys; 2023; 48(3):268-273. PubMed ID: 37969149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
    Meigooni AS; Sowards K; Soldano M
    Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric characterization of model Cs-1 Rev2 cesium-131 brachytherapy source in water phantoms and human tissues with MCNP5 Monte Carlo simulation.
    Wang J; Zhang H
    Med Phys; 2008 Apr; 35(4):1571-9. PubMed ID: 18491551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.